08.15.25 -- Environmental Monitoring Performance Qualification In Manufacturing Facilities

Join this expert-led Pace webinar to gain a clear, step-by-step strategy for managing extractables and leachables (E&L) risk. Discover how to assess materials, assign risk scores, and reduce testing burdens—all while staying aligned with USP requirements. Whether you're launching new products or prepping for regulatory submissions, this session will streamline your approach. Secure your spot today! Click here to learn more.

Review why, in early-phase drug development, precise sample preparation for UHPLC testing is crucial to ensure accurate and reliable stability data.

Discover an integrated approach that reduces particle size, enhances stability, and transforms nanosuspensions into scalable solid forms—boosting dissolution, bioavailability, and therapeutic success.

Explore regulatory insights, analytical strategies, and real-world case studies for effective nitrosamine control in APIs and drug products.

CDMO focused on active pharmaceutical ingredients (APIs) have long been vital components in the supply chain. Today, they are more than your enablers. CDMO have become strategic actors helping to reshape global outsourcing markets. A new report focuses on the new forces raising their importance.

Learn to minimize tablet defects like picking, sticking, and capping, as well as common issues and the critical role of blending in achieving quality tablets.

As demand grows, the need for advanced safety measures and reliable manufacturing technologies becomes critical, making it essential to partner with an experienced HPAPI manufacturer.

Join Outsourced Pharma Online on September 3rd at 2pm ET for a virtual panel discussion on overcoming difficulties outsourcing development and manufacturing, how does a biopharma organization (of any size) handle a multi-CDMO coordination. Registration is free for this digital event.

Gain insight into the many advantages of partnering with a CDMO, including extensive expertise and capabilities across oral solids and specialized nasal and pulmonary formulations.

Our scientists excel at building connections. Start a conversation today and witness the benefits of collaborating with a CDMO.

Witness how we defined workflows to assess and select solid forms in a cost and time-efficient manner that meets the needs of each individual program.